相似文献
1
Merging old and new perspectives on nicotinic acetylcholine receptors.
Biochem Pharmacol. 2014 May 1;89(1):1-11. doi: 10.1016/j.bcp.2014.01.029. Epub 2014 Jan 31.
2
Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.
Ann N Y Acad Sci. 2014 Oct;1327(1):27-45. doi: 10.1111/nyas.12421. Epub 2014 Apr 14.
3
An allosteric binding site of the α7 nicotinic acetylcholine receptor revealed in a humanized acetylcholine-binding protein.
J Biol Chem. 2018 Feb 16;293(7):2534-2545. doi: 10.1074/jbc.M117.815316. Epub 2017 Dec 13.
4
A Methyl Scan of the Pyrrolidinium Ring of Nicotine Reveals Significant Differences in Its Interactions with 7 and 42 Nicotinic Acetylcholine Receptors.
Mol Pharmacol. 2020 Aug;98(2):168-180. doi: 10.1124/mol.119.118786. Epub 2020 May 30.
5
Nicotinic acetylcholine receptors and modulation of learning in 4- and 27-month-old rabbits.
Neuropsychopharmacology. 2008 Nov;33(12):2820-30. doi: 10.1038/npp.2008.1. Epub 2008 Feb 6.
6
Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function.
Acta Pharmacol Sin. 2009 Jun;30(6):842-50. doi: 10.1038/aps.2009.69. Epub 2009 May 18.
7
alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex.
Eur J Neurosci. 2009 Feb;29(3):539-50. doi: 10.1111/j.1460-9568.2009.06613.x. Epub 2009 Jan 28.
8
Targeting alpha7 nicotinic acetylcholine receptors in the treatment of schizophrenia.
Curr Pharm Des. 2010;16(5):538-54. doi: 10.2174/138161210790361434.
9
Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: advantages and limitations.
Biochem Pharmacol. 2011 Oct 15;82(8):915-30. doi: 10.1016/j.bcp.2011.05.001. Epub 2011 May 14.
10
Nicotinic receptor pharmacology in silico: Insights and challenges.
Neuropharmacology. 2020 Oct 15;177:108257. doi: 10.1016/j.neuropharm.2020.108257. Epub 2020 Jul 29.
引用本文的文献
1
Variations in "Functional Site" Residues and Classification of Three-Finger Neurotoxins in Snake Venoms.
Toxins (Basel). 2025 Jul 24;17(8):364. doi: 10.3390/toxins17080364.
2
The Functional Topology of Phenylpiperazinium Agonists and Antagonists on the Nicotinic Acetylcholine Receptor Landscape: Pointing the Way for Future Therapeutic Management of Inflammation and Neuropathic Pain.
ACS Chem Neurosci. 2025 Aug 6;16(15):2901-2920. doi: 10.1021/acschemneuro.5c00216. Epub 2025 Jul 8.
3
Perspectives on the α5 nicotinic acetylcholine receptor in lung cancer progression.
Front Cell Dev Biol. 2025 Mar 12;13:1489958. doi: 10.3389/fcell.2025.1489958. eCollection 2025.
4
Alterations in Neuronal Nicotinic Acetylcholine Receptors in the Pathogenesis of Various Cognitive Impairments.
CNS Neurosci Ther. 2024 Oct;30(10):e70069. doi: 10.1111/cns.70069.
5
The role of kynurenines in migraine-related neuroimmune pathways.
J Headache Pain. 2024 Aug 7;25(1):129. doi: 10.1186/s10194-024-01833-z.
6
The human alpha7 nicotinic acetylcholine receptor is a host target for the rabies virus glycoprotein.
Front Cell Infect Microbiol. 2024 May 21;14:1394713. doi: 10.3389/fcimb.2024.1394713. eCollection 2024.
7
The Role of Alpha-7 Nicotinic Acetylcholine Receptors in Pain: Potential Therapeutic Implications.
Curr Neuropharmacol. 2025;23(2):129-144. doi: 10.2174/1570159X22666240528161117.
8
Functions and pharmacology of α2β2 nicotinic acetylcholine receptors; in and out of the shadow of α4β2 nicotinic acetylcholine receptors.
Biochem Pharmacol. 2024 Jul;225:116263. doi: 10.1016/j.bcp.2024.116263. Epub 2024 May 10.
9
The many enigmas of nicotine.
Adv Pharmacol. 2024;99:327-354. doi: 10.1016/bs.apha.2023.08.001. Epub 2023 Oct 17.
10
New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.
ACS Chem Neurosci. 2024 Feb 21;15(4):827-843. doi: 10.1021/acschemneuro.3c00720. Epub 2024 Feb 9.
本文引用的文献
1
Stoichiometry for activation of neuronal α7 nicotinic receptors.
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20819-24. doi: 10.1073/pnas.1315775110. Epub 2013 Dec 2.
2
Acute activation, desensitization and smoldering activation of human acetylcholine receptors.
PLoS One. 2013 Nov 14;8(11):e79653. doi: 10.1371/journal.pone.0079653. eCollection 2013.
3
Are nicotinic acetylcholine receptors coupled to G proteins?
Bioessays. 2013 Dec;35(12):1025-34. doi: 10.1002/bies.201300082.
4
Similar activity of mecamylamine stereoisomers in vitro and in vivo.
Eur J Pharmacol. 2013 Nov 15;720(1-3):264-75. doi: 10.1016/j.ejphar.2013.10.018. Epub 2013 Oct 23.
5
Multiple modes of α7 nAChR noncompetitive antagonism of control agonist-evoked and allosterically enhanced currents.
Mol Pharmacol. 2013 Sep;84(3):459-75. doi: 10.1124/mol.113.086462. Epub 2013 Jul 9.
6
Synthesis and evaluation of a conditionally-silent agonist for the α7 nicotinic acetylcholine receptor.
Bioorg Med Chem Lett. 2013 Jul 15;23(14):4145-9. doi: 10.1016/j.bmcl.2013.05.039. Epub 2013 May 23.
7
Point-to-point ligand-receptor interactions across the subunit interface modulate the induction and stabilization of conformational states of alpha7 nAChR by benzylidene anabaseines.
Biochem Pharmacol. 2013 Mar 15;85(6):817-28. doi: 10.1016/j.bcp.2013.01.010. Epub 2013 Jan 23.
8
The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia.
J Neuroimmunol. 2012 Oct 15;251(1-2):65-72. doi: 10.1016/j.jneuroim.2012.07.006. Epub 2012 Aug 9.
9
Intrinsically low open probability of α7 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures.
Mol Pharmacol. 2012 Oct;82(4):746-59. doi: 10.1124/mol.112.080317. Epub 2012 Jul 24.
10
Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia.
Neuropsychopharmacology. 2012 Apr;37(5):1134-43. doi: 10.1038/npp.2011.299. Epub 2011 Dec 14.
Zotero 插件